An announcement from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) is now available.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced a board meeting scheduled for April 28, 2025, to approve and publish the company’s first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance and operational progress, potentially impacting its market positioning and stakeholder interests.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company based in the People’s Republic of China, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products and services, focusing on enhancing healthcare solutions.
YTD Price Performance: -8.59%
Average Trading Volume: 49,155
Technical Sentiment Signal: Sell
Current Market Cap: $7.4B
For a thorough assessment of 2607 stock, go to TipRanks’ Stock Analysis page.